A Dose-exploration Study of EDP167 in HoFH

NCT07489209 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia (HoFH)

Interventions

DRUG: EDP167

Sponsor

Eddingpharm (Zhuhai) Co., Ltd.